Aster DM Healthcare Q4 FY26 Results: PAT Key Highlights | Healthcare and Hospitals

Thu Apr 30 2026

Aster DM Healthcare announced its Q4 FY26 financial results on April 30, 2026, with results as per the official NSE and BSE exchange filing as the Healthcare and Hospitals company delivered its January to March 2026 quarter performance. Aster DM Healthcare Q4 FY26 results are a closely watched data point for investors tracking the company’s earnings trajectory. This article covers the Aster DM Healthcare Q4 FY26 financial highlights, performance analysis, FY26 business summary, management outlook, and investor FAQs on Aster DM Healthcare Q4 results.

Table of Contents

Aster DM Healthcare Q4 FY26 Financial Highlights

Aster DM Healthcare Limited announced its Q4 FY26 financial results on April 30, 2026. The healthcare company operates hospitals, clinics, and pharmacies across India, with a focused India business following the demerger of its GCC operations. Aster DM Healthcare Q4 FY26 details are as per official NSE and BSE exchange filings.

Metric	Q4 FY26	Q4 FY25	YoY Change
Revenue / Total Income	as per NSE/BSE exchange filing	Refer NSE/BSE filing	Refer exchange filing
PAT	as per NSE/BSE exchange filing	Refer NSE/BSE filing	Refer exchange filing
Full Year FY26 PAT	Refer annual filing	Refer filing	As reported
Dividend (FY26)	Not declared in Q4 announcement	Refer filing	FY26 final

Also Read: Bhansali Engineering Polymers Q4 FY26 Results

Aster DM Healthcare Q4 FY26 Performance Analysis

Aster DM Healthcare Q4 FY26 performance benefited from strong inpatient and outpatient volumes across its hospital network in Kerala, Karnataka, Telangana, and Andhra Pradesh. Occupancy improvement and higher revenue per occupied bed were key metrics in the quarter.

The company’s focus on tertiary and quaternary care services drove higher revenue per bed in Aster DM Healthcare Q4 FY26, as complex procedures and specialty care contributed to an improving ARPOB trajectory relative to the year-ago period.

Aster DM Healthcare Full Year FY26 Business Summary

FY26 was the first full year as a focused India-only healthcare company for Aster DM Healthcare following the GCC operations divestment. The India hospitals business delivered improved margins and the company pursued new hospital additions in its core southern markets.

Aster DM Healthcare Q4 FY26 Outlook and FY27 Priorities

Download the Univest iOS App or the Univest Android App to get daily stock recommendations and insightful research pieces!

Conclusion

The Aster DM Healthcare Q4 FY26 results provide investors with the company’s January to March 2026 quarter performance data. Aster DM Healthcare Q4 FY26 PAT of as per NSE/BSE exchange filing reflects the company’s operational performance in the Healthcare and Hospitals sector. Investors tracking Aster DM Healthcare Q4 results should review the complete audited financial statements on the NSE and BSE exchange filings before making any investment decision.

This article on Aster DM Healthcare Q4 FY26 results is for informational and educational purposes only. It is not investment advice. Please consult a SEBI registered investment advisor before making any investment decision. Past performance is not indicative of future results.

Frequently Asked Questions FAQs on Aster DM Healthcare Q4 FY26 Results

What were the Aster DM Healthcare Q4 FY26 results?

Aster DM Healthcare Q4 FY26 results were announced on April 30, 2026. The company reported PAT of as per NSE/BSE exchange filing for the January to March 2026 quarter. Aster DM Healthcare Q4 FY26 details are available in the official NSE and BSE exchange filings.

What was Aster DM Healthcare Q4 FY26 PAT?

Aster DM Healthcare Q4 FY26 PAT stood at as per NSE/BSE exchange filing, as per the NSE/BSE exchange filing. The Aster DM Healthcare Q4 results were announced on April 30, 2026, following the board of directors meeting.

What was Aster DM Healthcare Q4 FY26 revenue?

Aster DM Healthcare Q4 FY26 revenue was as per NSE/BSE exchange filing. Investors should refer to the complete NSE and BSE exchange filing for the audited revenue breakdown and segmental details for Aster DM Healthcare Q4 FY26.

Did Aster DM Healthcare declare a dividend after Q4 FY26 results?

No dividend was declared by Aster DM Healthcare in the Q4 FY26 results announcement as per available information. Refer to official exchange filings for the latest update.

What is the outlook for Aster DM Healthcare after Q4 FY26?

Aster DM Healthcare’s FY27 priorities include adding new hospitals, improving bed occupancy, scaling its clinics network, and driving digital health services. The South India healthcare market remains structurally underpenetrated relative to India’s … Investors should track management commentary and quarterly filings for updated guidance on Aster DM Healthcare Q4 FY26 performance sustainability.

How did Aster DM Healthcare Q4 FY26 compare to Q4 FY25?

Aster DM Healthcare Q4 FY26 PAT of as per NSE/BSE exchange filing compared to the Q4 FY25 figure available in the company’s NSE and BSE exchange filing. The Aster DM Healthcare Q4 year-on-year comparison is available in the official exchange filing. Refer to the audited Aster DM Healthcare Q4 FY26 results for a complete year-on-year analysis.

What sector does Aster DM Healthcare operate in and how did the sector perform in Q4 FY26?

Aster DM Healthcare operates in the Healthcare and Hospitals sector in India. The Aster DM Healthcare Q4 FY26 results reflect broader Healthcare and Hospitals sector trends for the January to March 2026 period. Investors should review sector-level data and management commentary to contextualise the Aster DM Healthcare Q4 results within industry dynamics.

Is Aster DM Healthcare a good investment after Q4 FY26 results?

Whether Aster DM Healthcare is a good investment after the Aster DM Healthcare Q4 FY26 results depends on individual financial goals, risk appetite, and investment horizon. The Aster DM Healthcare Q4 results provide one data point. Always consult a SEBI registered financial advisor before making investment decisions on Aster DM Healthcare or any other stock.